Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vigilant Ops is a healthcare-focused cybersecurity software company that developed a platform for Software Bill of Materials (SBOM) lifecycle management, including SBOM generation, monitoring, management, secure sharing, and compliance support. The company has been used by medical device manufacturers and healthcare organizations to manage software supply chain risk, monitor vulnerabilities, and support regulatory requirements such as FDA cybersecurity guidance and 510(k) submissions. Although not a drug-development biotech or pharma company, it operates in the healthcare technology ecosystem by serving medtech and healthcare customers. Vigilant Ops was founded in 2019 in Pittsburgh and raised seed financing from DataTribe in 2024. In October 2025, the company was acquired by C2A Security, and its team and capabilities were integrated into C2A Security's broader product security platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vigilant Ops.